Details for Patent: 8,153,689
✉ Email this page to a colleague
Which drugs does patent 8,153,689 protect, and when does it expire?
Patent 8,153,689 protects XENLETA and is included in two NDAs.
This patent has forty-four patent family members in thirty-one countries.
Summary for Patent: 8,153,689
Title: | Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
Abstract: | Disclosed are pleuromutilin derivatives of formula (I) ##STR00001## and their use in the treatment of diseases mediated by microbes. |
Inventor(s): | Mang; Rosemarie (Vienna, AT), Heilmayer; Werner (Zillingtal, AT), Badegruber; Rudolf (Vienna, AT), Strickmann; Dirk B. (Vienna, AT), Novak; Rodger (Vienna, AT), Ferencic; Mathias (Vienna, AT), Bulusu; Atchyuta Rama Chandra Murty (Perchtoldsdorf, AT) |
Assignee: | Nabriva Therapeutics AG (Vienna, AT) |
Application Number: | 13/252,732 |
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,153,689
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nabriva | XENLETA | lefamulin acetate | SOLUTION;INTRAVENOUS | 211673-001 | Aug 19, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
Nabriva | XENLETA | lefamulin acetate | TABLET;ORAL | 211672-001 | Aug 19, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,153,689
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
07450053 | Mar 20, 2007 |
International Family Members for US Patent 8,153,689
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2137143 | ⤷ Sign Up | CA 2020 00046 | Denmark | ⤷ Sign Up |
European Patent Office | 2137143 | ⤷ Sign Up | PA2020531 | Lithuania | ⤷ Sign Up |
European Patent Office | 2137143 | ⤷ Sign Up | LUC00178 | Luxembourg | ⤷ Sign Up |
European Patent Office | 2137143 | ⤷ Sign Up | CR 2020 00046 | Denmark | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |